![.](tbl_spacer.png) 0 Table of Contents |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 1 Home |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 2 Api Input |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 3 Api Query |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 4 Architecture |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 5 Examples |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 6 Extensions |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 7 Profiles |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 8 Reference Implementation |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 9 Resource Graph |
![.](tbl_spacer.png) ![.](tbl_vjoin.png) 10 Terminology |
![.](tbl_spacer.png) ![.](tbl_vjoin_end-open.png) 11 Artifacts Summary |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.1 CapabilityStatement representing the server requirements for a FHIR server |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.2 ACT-NOW diagnosis |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.3 ACT-NOW medication administration |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.4 ACT-NOW medication request |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.5 ACT-NOW patient |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.6 Body Surface Area |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.7 Clinical M-score |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.8 Clinical N-score |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.9 Clinical T-score |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.10 clinical TNM group score |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.11 Creatinine Clearance |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.12 Cycle Careplan |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.13 ECOG score |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.14 Estrogen Receptor status |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.15 Gleason score |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.16 Height |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.17 HER2 status |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.18 Histology |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.19 Pathological M-score |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.20 Pathological N-score |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.21 Pathological T-score |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.22 Pathological TNM group score |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.23 PR status |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.24 Regimen Careplan |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.25 Weight |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.26 ClinicalTrial |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.27 CourseNumber |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.28 CycleCount |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.29 CycleDay |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.30 CycleNumber |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.31 CyclePlannedLength |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.32 DependsOn |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.33 DoseAdjustmentReason |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.34 FacilityAdministered |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.35 IOT |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.36 LastAdminDate |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.37 PrescribedDose |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.38 RecurrenceType |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.39 Regimen type |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.40 RegimenDiscontinued |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.41 RegimenOTU |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.42 Basis of diagnosis |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.43 Dose adjustment reason |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.44 ECOG status |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.45 ER status |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.46 ER status |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.47 HER2 status |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.48 Intent of treatment |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.49 Outcome of a regimen |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.50 Patient factors when discontinuing a regimen |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.51 The reason why a regimen was discontinued |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.52 Toxicity reasons why a regimen was discontinued |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.53 Type of recurrence |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.54 Outcome of a regimen |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.55 The reason why a regimen was discontinued |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.56 bsa |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.57 careplan-regimen-1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.58 careplan-regimen-2 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.59 Clincial M value |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.60 Clincial N value |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.61 Clinical T value |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.62 Clinical TNM group |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.63 cp-supporting-info |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.64 CreatinineClearance |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.65 Cycle 1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.66 ERStatus |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.67 Example practitioner |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.68 ExObservationECOG |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.69 ExObservationGleason |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.70 ExObservationHeight |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.71 ExObservationNoValueSystemWeight |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.72 ExObservationWeight |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.73 HER2Status |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.74 Histology: Small cell lung cancer |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.75 Lorrie Lung |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.76 medicationadministration-1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.77 medicationrequest-1 |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.78 Pathological M value |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.79 Pathological N value |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.80 Pathological T value |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.81 Pathological TNM group |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin.png) 11.82 PRStatus |
![.](tbl_spacer.png) ![.](tbl_blank.png) ![.](tbl_vjoin_end.png) 11.83 Small cell lung cancer diagnosis |